Clinical nuclear medicineHumansFemaleAgedTumor Lysis SyndromeFatal Outcome
Fatal Tumor Lysis Syndrome Following [ 177 Lu]Lu-DOTA-TATE Therapy.
Alexandre Jadoul, Marine Stoffels, Laurence Lousberg, Mounira El-Demery, Celine Derwael
Published: 202610.1097/RLU.0000000000006165
Abstract
We present a 69-year-old woman who developed a lethal tumor lysis syndrome (TLS) after a first cycle of [ 177 Lu]Lu-DOTA-TATE, administered to treat a well-differentiated metastatic lung carcinoid tumor with liver, bone, and splenic progression. The…
Preview only. Read the full abstract at the source